General Manager Josef Cachia will be parting ways with Hal-Far-based pharmaceutical company PharOS MT after four years of employment.

Josef Cachia / LinkedIn

“The experience gained throughout the last four years have definitely shaped me into what I am today. I have been blessed to share such experiences with great colleagues and mentors,” Mr Cachia wrote on social media.

“Thank you to everyone who has been part of this journey. Now, time to take a few days off from life before starting a whole new chapter,” he continued.

Mr Cachia joined PharOS MT in March 2018, after a two-year tenure as Production and Pharm Tech Manager at Teva Pharmaceuticals.

His experience in the local pharmaceutical industry goes further back, having also served as Pharm Tech Department Manager at Allergan and Process support / Validation Manager at Teva / Actavis Generics.

Related

Charles Xuereb / Trident Estates Annual Report

Firms not offering flexibility find it difficult to recruit and retain employees, says Trident Estates CEO

30 May 2024
by Fabrizio Tabone

Charles Xuereb notes that the office environment has an impact on corporate culture and lifestyles tenants want to promote.

‘Technology is changing at a rapid pace, so staying at the forefront means we need to adapt’ – BMIT CEO

30 May 2024
by Helena Grech

As the leading local technology company shares its financial results for 2023, CEO Christian Sammut attests that forward-looking plans for ...

Medserv and Regis ‘have forged a powerful alliance,’ says CEO

30 May 2024
by Robert Fenech

The company is celebrating 50 years from the founding of Medserv

‘Past year was predominantly marked by growing competitive pressures,’ says Farsons CEO

30 May 2024
by Fabrizio Tabone

During the financial year ended 31st January 2024, Farsons Group’s pre-tax profit rose by 4.9% to €16.1 million.

Close Bitnami banner
Bitnami